Inventors:
John T. FLYNN - Elmsford NY, US
Quan WEN - New York NY, US
Takayuki NAGASAKI - New York NY, US
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - New York NY
International Classification:
A61K 31/197, G01N 33/50
Abstract:
The invention provides methods to treat oxygen-induced retinopathy using complement factor C3aR antagonists.